Voyageur Pharmaceuticals Ltd. (TSXV:VM)
0.1900
0.00 (0.00%)
May 2, 2025, 3:59 PM EDT
Voyageur Pharmaceuticals Balance Sheet
Financials in millions CAD. Fiscal year is December - November.
Millions CAD. Fiscal year is Dec - Nov.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 30, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | 2015 - 2019 |
Cash & Equivalents | 0.17 | 0 | 0.03 | 0.81 | 0 | Upgrade
|
Short-Term Investments | 0 | 0 | 0.01 | 0.01 | - | Upgrade
|
Cash & Short-Term Investments | 0.17 | 0.01 | 0.04 | 0.82 | 0 | Upgrade
|
Cash Growth | 2927.20% | -85.11% | -95.42% | 27500.91% | -96.08% | Upgrade
|
Other Receivables | 0.05 | 0.04 | 0.02 | 0.04 | 0.01 | Upgrade
|
Receivables | 0.05 | 0.04 | 0.02 | 0.04 | 0.01 | Upgrade
|
Inventory | 0.07 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Prepaid Expenses | 0.07 | 0.04 | 0.09 | 0.02 | - | Upgrade
|
Total Current Assets | 0.36 | 0.09 | 0.16 | 0.89 | 0.03 | Upgrade
|
Property, Plant & Equipment | 2.23 | 2.06 | 1.92 | 1.67 | 1.24 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Total Assets | 2.6 | 2.16 | 2.1 | 2.57 | 1.28 | Upgrade
|
Accounts Payable | 0.91 | 0.22 | 0.52 | 0.55 | 0.57 | Upgrade
|
Short-Term Debt | 0.02 | - | - | - | 0.21 | Upgrade
|
Current Portion of Leases | - | - | - | 0.02 | 0.01 | Upgrade
|
Other Current Liabilities | 1.17 | 0.46 | 0.07 | 0.05 | 0.11 | Upgrade
|
Total Current Liabilities | 2.09 | 0.67 | 0.59 | 0.62 | 0.91 | Upgrade
|
Long-Term Debt | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | Upgrade
|
Long-Term Leases | - | - | - | - | 0.01 | Upgrade
|
Other Long-Term Liabilities | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
Total Liabilities | 2.15 | 0.73 | 0.63 | 0.66 | 0.97 | Upgrade
|
Common Stock | 9.14 | 8.69 | 7.55 | 6.33 | 3.44 | Upgrade
|
Additional Paid-In Capital | 2.13 | 1.86 | 1.64 | 1.55 | 0.79 | Upgrade
|
Retained Earnings | -10.84 | -9.13 | -7.73 | -5.97 | -3.92 | Upgrade
|
Comprehensive Income & Other | 0.02 | 0.01 | - | - | - | Upgrade
|
Shareholders' Equity | 0.45 | 1.44 | 1.46 | 1.91 | 0.31 | Upgrade
|
Total Liabilities & Equity | 2.6 | 2.16 | 2.1 | 2.57 | 1.28 | Upgrade
|
Total Debt | 0.06 | 0.04 | 0.03 | 0.04 | 0.27 | Upgrade
|
Net Cash (Debt) | 0.11 | -0.03 | 0.01 | 0.78 | -0.27 | Upgrade
|
Net Cash Growth | - | - | -98.46% | - | - | Upgrade
|
Net Cash Per Share | 0.00 | -0.00 | 0.00 | 0.01 | -0.00 | Upgrade
|
Filing Date Shares Outstanding | 139.47 | 138.81 | 132.7 | 102.02 | 88.92 | Upgrade
|
Total Common Shares Outstanding | 139.47 | 132.7 | 115.43 | 101.82 | 71.37 | Upgrade
|
Working Capital | -1.74 | -0.59 | -0.43 | 0.27 | -0.88 | Upgrade
|
Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.02 | 0.00 | Upgrade
|
Tangible Book Value | 0.45 | 1.44 | 1.46 | 1.91 | 0.31 | Upgrade
|
Tangible Book Value Per Share | 0.00 | 0.01 | 0.01 | 0.02 | 0.00 | Upgrade
|
Machinery | 0.02 | 0.02 | 0.02 | 0.08 | 0.06 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.